Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2012
09/25/2012US8273890 Thiophene-imidazopyridines
09/25/2012US8273767 Bicyclic-substituted amines as histamine-3 receptor ligands
09/25/2012US8273765 Bicyclo-pyrazoles and pharmaceutical compositions comprising them
09/25/2012US8273764 Fused heterocyclic compounds and use thereof
09/25/2012US8273760 Indolo[3,2-c]quinoline compounds
09/25/2012US8273755 4-methylpyridopyrimidinone compounds
09/25/2012US8273744 AMPK modulators
09/25/2012CA2517769C Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments
09/20/2012WO2012125663A2 Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists
09/20/2012WO2012125622A1 Substituted adipic acid amides and uses thereof
09/20/2012WO2012124825A1 Sulfonamide compounds having trpm8 antagonistic activity
09/20/2012WO2012124782A1 Condensed heterocyclic compound
09/20/2012WO2012124775A1 Nitrogen-containing saturated heterocyclic compound
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012124412A1 Nitrogen-containing aromatic compounds and organic electroluminescent elements
09/20/2012WO2012123745A1 Pyrrolopyridineamino derivatives as mps1 inhibitors
09/20/2012WO2012123312A1 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
09/20/2012WO2011005295A8 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
09/20/2012US20120238755 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
09/20/2012US20120238752 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production
09/20/2012US20120238751 Tricyclic gyrase inhibitors
09/20/2012US20120238748 Novel compounds having phenanthroline structure
09/20/2012US20120238597 Inhibiting EPH B-3 Kinase
09/20/2012US20120238588 1H-Pyrrolo[2,3-B]Pyridines
09/20/2012US20120238587 Novel pyridopyrimidine derivatives and use thereof
09/20/2012US20120238583 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
09/20/2012US20120238571 Indazole derivatives as pi 3-kinase
09/20/2012US20120238570 Inhibitors of the hedgehog pathway
09/20/2012US20120238568 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use
09/20/2012US20120238565 Triazolopyridine compounds and their use as ask inhibitors
09/20/2012US20120238559 Novel compounds
09/20/2012US20120238553 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
09/20/2012US20120238546 Gamma secretase modulators
09/20/2012US20120238452 Chemical compounds and their use as pesticides
09/20/2012US20120235129 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2830143A1 Pyrrolopyridineamino derivatives as mps1 inhibitors
09/20/2012CA2828378A1 Nitrogen-containing saturated heterocyclic compound
09/20/2012CA2826678A1 Sulfonamide compounds having trpm8 antagonistic activity
09/19/2012EP2500346A1 Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent element
09/19/2012EP2499141A2 Polymorphs of nevirapine and method for increasing the solubility of a transcriptase inhibitor composition
09/19/2012EP2499140A1 N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/19/2012EP2499139A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/19/2012EP2499138A1 Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
09/19/2012EP2499127A1 Hepatitis c virus inhibitors
09/19/2012EP2499121A1 Oxazoline derivatives for treatment of cns disorders.
09/19/2012EP2499117A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
09/19/2012EP2498826A1 Labelled pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their use in diagnostic methods
09/19/2012EP2498775A1 New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives
09/19/2012EP2498600A1 Filamin a-binding anti-inflammatory analgesic
09/19/2012CN102686590A Pyrazoline dione derivatives as NADPH oxidase inhibitors
09/19/2012CN102686589A Ethynyl derivatives
09/19/2012CN102686588A Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
09/19/2012CN102686587A Azaindole glucokinase activators
09/19/2012CN102686586A Histamine H3 inverse agonists and antagonists and methods of use thereof
09/19/2012CN102686580A Imidazole derivative as casein kinase inhibitors
09/19/2012CN102686572A Oxazoline derivatives for treatment of CNS disorders
09/19/2012CN102686570A Mesoionic pesticides
09/19/2012CN102675314A Method for synthesizing apixaban
09/19/2012CN102675313A Preparation method of moxifloxacin hydrochloride
09/19/2012CN102675312A Synthesis method of ethyl 1H-pyrrolo[2,3-C]pyridyl-2-carboxylate
09/19/2012CN102675311A Fluoro-acrylamide derivative
09/19/2012CN102675310A Method for preparing pyrazol heteroaromatic compound
09/19/2012CN102675309A Application of triazole and pyridine derivative in preparing antifungal drug
09/19/2012CN102675308A Method for preparing 8-benzyl-2,8-diazabicyclo(4.3.0) nonane
09/19/2012CN102675307A Method for preparing chiral compound 8-phenethyl-2,8-diazabicyclo[4.3.0]nonane
09/19/2012CN102675306A Preparing method of moxifloxacin or slat thereof
09/19/2012CN102675305A Imidazopyridine compounds, as well as preparation method and application thereof
09/19/2012CN102675286A Indazoles compound, and preparation method and application thereof, and medical composition
09/19/2012CN102675031A Beta-dinaphthyl anthracene and derivative thereof and preparation method
09/19/2012CN102669121A Application of triazolopyrimidine derivative in preparation of medicine for resisting agricultural fungi
09/19/2012CN102127079B Pyrrolo-pyrazin-carboline diketone compounds and preparation method and applications thereof
09/19/2012CN101492448B 7'-aza indirubin compounds for antineoplastic medicament
09/19/2012CN101374828B Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
09/18/2012US8269000 Substituted pyrimidine and triazine compounds
09/18/2012US8268994 Fused ring heterocycle kinase modulators
09/18/2012US8268859 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
09/18/2012US8268858 e.g. 5-(3-methoxybenzyloxy)-1H-pyrrolo[2,3-b]pyridine; protein kinases inhibitor; central nervous system disorders; Alzheimer's disease; Parkinson's disease; anticancer, antitumor agents; analgesics; cogestive heart failure; skin disorders; inflammatory bowel disorders; transplant rejection
09/18/2012US8268857 Compositions and methods for inhibiting TGF-β
09/18/2012US8268856 Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter
09/18/2012US8268855 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
09/18/2012US8268854 Aza-beta-carbolines and methods of using same
09/18/2012US8268852 Heterocyclic inhibitors of MEK and methods of use thereof
09/18/2012US8268842 Fused ring 4-oxopyrimidine derivative
09/18/2012US8268840 Pyrimidinyl pyridone inhibitors of kinases
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268828 Inhibitors of the chemokine receptor CxCR3
09/18/2012US8268826 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
09/18/2012US8268457 Organic electroluminescent device and material for organic electroluminescent device
09/18/2012CA2601542C Method for making 1-substituted 1h-imidazo[4,5-c]quinolin-4-amine compounds and intermediates therefor
09/13/2012WO2012121992A1 Mst1 kinase inhibitors and methods of their use
09/13/2012WO2012121361A1 Dispiropyrrolidine derivative
09/13/2012WO2012121145A1 Electrode active material, electrode, and secondary battery
09/13/2012WO2012119690A1 Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses
09/13/2012WO2012087182A3 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
09/13/2012US20120232275 Process for preparing 5-fluoro-1h-pyrazolo [3,4-b] pyridin-3-amine and derivatives thereof
09/13/2012US20120232241 Nitrogen-containing condensed heterocyclic compounds for oleds
09/13/2012US20120232109 3-substituted sulfonyl piperidine derivative
09/13/2012US20120232108 Gamma secretase modulators
09/13/2012US20120232081 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 646